Login

Insider Transactions

What Generate Biomedicines, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 12
Sells 1 1
Total trades 1 25

Shares traded

3 months 12 months
Acquired 0 76,719,605
Disposed 1,000 1,000
Net activity −1,000 +76,718,605

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Arnold Frances Director Sep 01 Open-market sale · S −1,000 $16.00 −$16K 231,472
Nally Michael Chief Executive Officer Mar 04 Open-market buy · P +20,000 $12.00 +$240K 572,707
Silvers Jason President & CFO Mar 02 Open-market buy · P +1,000 $16.00 +$16K 1,000
Silvers Jason President & CFO Mar 02 Open-market buy · P +500 $16.00 +$8K 500
Silvers Jason President & CFO Mar 02 Open-market buy · P +500 $16.00 +$8K 500
Grous Beth Chief People Officer Mar 02 Open-market buy · P +300 $16.00 +$4.8K 300
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 1,562,500
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 4,340,252
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 15,264,724
Afeyan Noubar Director Mar 02 Derivative Conversion · C +2,777,752 2,777,752
Afeyan Noubar Director Mar 02 Derivative Conversion · C +2,777,752 2,777,752
Afeyan Noubar Director Mar 02 Derivative Conversion · C +987,491 987,491
Afeyan Noubar Director Mar 02 Derivative Conversion · C +13,702,224 13,702,224
Afeyan Noubar Director Mar 02 Derivative Conversion · C +12,723,940 12,723,940
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 1,562,500
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 4,340,252
Afeyan Noubar Director Mar 02 Open-market buy · P +1,562,500 $16.00 +$25M 15,264,724
Afeyan Noubar Director Mar 02 Derivative Conversion · C +2,777,752 2,777,752
Afeyan Noubar Director Mar 02 Derivative Conversion · C +2,777,752 2,777,752
Afeyan Noubar Director Mar 02 Derivative Conversion · C +987,491 987,491

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support